Reports for TEVA-SPIRONOLACTONE/HCTZ

Brand name
TEVA-SPIRONOLACTONE/HCTZ

Company Name

TEVA CANADA LIMITED

Drug Identification Number

00613231

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • C03EA
  • C03EA

Anatomical Therapeutical Chemical (ATC) Descriptor

  • DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
  • DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2017-08-02 2017-11-07 18021
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2020-04-03 2020-06-04 110785
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2020-11-06 2021-02-05 128022
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2022-03-24 2022-04-21 157262
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2022-12-01 2023-02-16 176842
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2025-07-18 2025-08-29 263110
TEVA-SPIRONOLACTONE/HCTZ 100 Resolved 2025-10-16 2026-01-08 269678

Showing 1 to 7 of 7

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0